These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34862601)

  • 1. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
    Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation.
    Şavkli AÖ; Çetin BA; Acar Z; Özköse Z; Behram M; Çaypinar SS; Tayyar A; Yüksel MA
    J Obstet Gynaecol; 2020 Jul; 40(5):649-653. PubMed ID: 31462132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal red blood cell alloimmunization requiring intrauterine transfusion: a comparative study on management and outcome depending on the type of antibody.
    Phung TV; Houfflin-Debarge V; Ramdane N; Ghesquière L; Delsalle A; Coulon C; Subtil D; Vaast P; Garabedian C
    Transfusion; 2018 May; 58(5):1199-1205. PubMed ID: 29512164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
    Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.
    Vlachodimitropoulou E; Lo TK; Bambao C; Denomme G; Seaward GR; Windrim R; Tessier F; Kelly E; Van Mieghem T; Ryan G
    Br J Haematol; 2023 Jan; 200(1):100-106. PubMed ID: 36100813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
    Walsh CA; Russell N; McAuliffe FM; Higgins S; Mahony R; Carroll S; McParland P
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):235-9. PubMed ID: 24075591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study.
    Van't Oever RM; Zwiers C; de Haas M; le Cessie S; Lopriore E; Oepkes D; Verweij EJTJ
    BJOG; 2024 May; 131(6):769-776. PubMed ID: 37743689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
    Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of optimal timing of serial in-utero transfusions in red-cell alloimmunization.
    Friszer S; Maisonneuve E; Macé G; Castaigne V; Cortey A; Mailloux A; Pernot F; Carbonne B
    Ultrasound Obstet Gynecol; 2015 Nov; 46(5):600-5. PubMed ID: 25523966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
    Maisonneuve E; Dugas A; Friszer S; Toly-Ndour C; Cariot L; Dhombres F; Cortey A; Mailloux A; Carbonne B; Jouannic JM
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak systolic velocity of fetal middle cerebral artery to predict anemia in Red Cell Alloimmunization in un-transfused and transfused fetuses.
    Abdelshafi S; Okasha A; Elsirgany S; Khalil A; El-Dessouky S; AbdelHakim N; Elanwary S; Elsheikhah A
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():437-442. PubMed ID: 33571914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)].
    Girault A; Friszer S; Maisonneuve E; Guilbaud L; Cortey A; Jouannic JM
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):119-124. PubMed ID: 28403966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U; Larsson M; Baird A; Waring G; Athiraman N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
    Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
    J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal and Neonatal Reticulocyte Count Response to Intrauterine Transfusion for the Treatment of Red Blood Cell Alloimmunization.
    Lee AJ; Leonard A; Markham KB
    J Pediatr Hematol Oncol; 2022 Nov; 44(8):e1046-e1049. PubMed ID: 35380549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.